| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | May 14, 2026 | Sale | $9.50 | 403 | 3,829 | 94,821 | May 15, 2026, 04:08 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Feb 17, 2026 | Sale | $8.63 | 378 | 3,262 | 99,429 | Feb 19, 2026, 04:02 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Sep 15, 2025 | Sale | $6.43 | 401 | 2,578 | 27,710 | Sep 16, 2025, 04:33 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Jul 29, 2025 | Sale | $4.37 | 191 | 835 | 27,223 | Jul 30, 2025, 04:56 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Mar 04, 2025 | Sale | $6.29 | 3,548 | 22,317 | 27,414 | Mar 06, 2025, 04:24 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Jul 30, 2024 | Sale | $1.06 | 2,883 | 3,056 | 326,628 | Jul 31, 2024, 04:14 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Mar 01, 2024 | Sale | $1.20 | 6,155 | 7,386 | 329,511 | Mar 04, 2024, 07:40 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Feb 29, 2024 | Sale | $1.17 | 16,311 | 19,084 | 335,666 | Mar 04, 2024, 07:40 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Feb 15, 2024 | Sale | $1.33 | 5,847 | 7,783 | 163,871 | Feb 20, 2024, 04:59 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Jul 28, 2023 | Sale | $1.70 | 2,845 | 4,837 | 156,286 | Aug 01, 2023, 05:37 PM | |
| KPTI | Karyopharm Therapeutics Inc. | Stuart Poulton | EVP, Chief Development Officer | Feb 15, 2023 | Sale | $3.19 | 5,869 | 18,717 | 64,335 | Feb 17, 2023, 04:07 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More